Brentuximab shrunk tumors in resistant Hodgkin lymphoma - ONA
Links shared publicly online about this topic.
- 658total visits
Brentuximab shrunk tumors in resistant Hodgkin lymphoma - ONA
An investigational agent for the treatment of Hodgkin lymphoma has yielded very strong results in a phase II trial of heavily pretreated persons with relapsed or refractory disease.
View full resource at oncologynurseadvisor.com
Tags: Cancer, Lymphoma, Hodgkin Lymphoma, Disease and Condition, disease
Most Recently Shared on December 13, 2010 at 12:56 pm By:
Brentuximab shrunk tumors in resistant Hodgkin lymphoma http://goo.gl/fb/gyK4p
OncLive | Resources and information for oncologists to provide the best patient care
onclive.com — “Onclive provides resources and information for Oncologist to provide the best patient care” View full resource at onclive.com
Most Recently Shared on June 4, 2010 at 2:52 pm By:
http://www.onclive.com is up and running! Check out ASCO 2010 for Live Coverage as well as our current publications.
Advertisement
